EUSA Pharma To Pay $180K Over Inflated Medicare Claims

Law360, New York (March 23, 2012, 4:55 PM EDT) -- EUSA Pharma USA Inc. has agreed to pay $180,000 to resolve a former employee’s $10 million whistleblower suit accusing the pharmaceutical firm of advising doctors to submit inflated claims to Medicare for certain imaging scans, the U.S. Department of Justice said Friday.

Langhorne, Pa.-based EUSA allegedly violated the False Claims Act by telling doctors to submit extra claims for certain scans after the use of its radiopharmaceutical ProstaScint, a diagnostic scanning chemical used to detect prostate cancer, according to prosecutors, who noted that the Society of...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.